Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practice
{{output}}
Background: The advent of oral disease-modifying therapies fundamentally changed the treatment of multiple sclerosis. Nevertheless, impressions of their relative efficacy and tolerability are primarily founded on expert opinion. ... ...
